N
MACK

Nuveen’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Nuveen’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,719
Closed -$203K – 3482
2024
Q1 		$203K Hold
13,719
– – ﹤0.01% 3183
2023
Q4 		$184K Hold
13,719
– – ﹤0.01% 3227
2023
Q3 		$169K Hold
13,719
– – ﹤0.01% 3065
2023
Q2 		$169K Buy
+13,719
New +$172K ﹤0.01% 3117
2019
Q3 		– Sell
-602,214
Closed -$2.87M – 3295
2019
Q2 		$2.87M Buy
+602,214
New +$2.85M ﹤0.01% 2259

Other funds holding MACK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $674M AUM 24.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return